An exhaustive comprehension of onco-cardiology or cardio-oncology is fundamental for the powerful treatment of malignancy patients. Practically all antineoplastic operators are connected with cardiotoxicity. All patients who are being considered for chemotherapy, particularly the individuals who have earlier history of heart malady ought to experience point by point cardiovascular assessment to streamline the treatment. Serial examination of left ventricular systolic capacity and heart biomarkers may likewise be considered in the chosen populaces of patient. Cardio-harmful impacts of chemotherapy can be diminished by the successive utilization of angiotensin-changing over inhibitors of compound, angiotensin receptor blockers, or beta-blockers. Antiplatelet or anticoagulation treatment may be brought in patients with a potential hyper-coagulable state related with chemotherapy or disease.